Clinical Trial Update: A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial of carboplatin and gemcitabine plus bevacizumab in ovarian, fallopian tube, or primary peritoneal cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Genentech, Inc. | Conditions: Ovarian Cancer | Phase 3 | Status: COMPLETED | Results posted: 2011-11-03